Jeffrey W. Cramer

1.9k total citations
20 papers, 1.3k citations indexed

About

Jeffrey W. Cramer is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Jeffrey W. Cramer has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Jeffrey W. Cramer's work include Tuberculosis Research and Epidemiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jeffrey W. Cramer is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jeffrey W. Cramer collaborates with scholars based in United States, United Kingdom and India. Jeffrey W. Cramer's co-authors include Patrick C. May, James E. Audia, Jeffrey S. Nissen, Jennie Taylor, Steven M. Paul, John R. Cirrito, Mark Odell, Maia Parsadanian, Ronald B. DeMattos and Kelly R. Bales and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and The FASEB Journal.

In The Last Decade

Jeffrey W. Cramer

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey W. Cramer United States 14 639 450 346 202 141 20 1.3k
Jeffrey S. Nissen United States 13 651 1.0× 424 0.9× 338 1.0× 142 0.7× 223 1.6× 16 1.2k
Jacques Bruhwyler Belgium 19 307 0.5× 325 0.7× 349 1.0× 168 0.8× 97 0.7× 71 1.3k
W. Gsell Germany 24 443 0.7× 430 1.0× 438 1.3× 43 0.2× 172 1.2× 47 1.5k
Mathias Hallberg Sweden 27 396 0.6× 1.0k 2.3× 876 2.5× 104 0.5× 98 0.7× 116 2.1k
Péter Serfózó United States 19 197 0.3× 641 1.4× 604 1.7× 52 0.3× 68 0.5× 45 1.4k
Suzhen Dong China 18 289 0.5× 437 1.0× 166 0.5× 261 1.3× 114 0.8× 53 1.1k
Kenji Onodera Japan 24 163 0.3× 832 1.8× 413 1.2× 104 0.5× 105 0.7× 99 1.9k
Natasja de Bruin Germany 25 194 0.3× 525 1.2× 562 1.6× 80 0.4× 237 1.7× 64 1.5k
Jean‐Marie Gillardin France 18 205 0.3× 248 0.6× 323 0.9× 56 0.3× 79 0.6× 31 840
F. Gualtieri Italy 18 110 0.2× 645 1.4× 390 1.1× 177 0.9× 115 0.8× 68 1.5k

Countries citing papers authored by Jeffrey W. Cramer

Since Specialization
Citations

This map shows the geographic impact of Jeffrey W. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey W. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey W. Cramer more than expected).

Fields of papers citing papers by Jeffrey W. Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey W. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey W. Cramer. The network helps show where Jeffrey W. Cramer may publish in the future.

Co-authorship network of co-authors of Jeffrey W. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey W. Cramer. A scholar is included among the top collaborators of Jeffrey W. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey W. Cramer. Jeffrey W. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castner, Stacy A., Linli Zhang, Charles R. Yang, et al.. (2023). Effects of DPTQ, a novel positive allosteric modulator of the dopamine D1 receptor, on spontaneous eye blink rate and spatial working memory in the nonhuman primate. Psychopharmacology. 240(5). 1033–1048. 1 indexed citations
2.
Zuniga, Edison S., Aaron Korkegian, Steven F. Mullen, et al.. (2017). The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents. Bioorganic & Medicinal Chemistry. 25(15). 3922–3946. 44 indexed citations
3.
Odingo, Joshua, Mai A. Bailey, Megan Files, et al.. (2017). In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis. ACS Omega. 2(9). 5873–5890. 20 indexed citations
4.
Moraski, Garrett C., Yong Cheng, Sang‐Hyun Cho, et al.. (2016). Imidazo[1,2- a ]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection In Vivo. Antimicrobial Agents and Chemotherapy. 60(8). 5018–5022. 24 indexed citations
5.
Poe, Michael M., Guanguan Li, Kelly A. Teske, et al.. (2016). Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy. Journal of Medicinal Chemistry. 59(23). 10800–10806. 37 indexed citations
6.
Svensson, Kjell, James P. Beck, Junliang Hao, et al.. (2016). Behavioral Effects of a Novel Allosteric Potentiator of the Dopamine D1 Receptor in Human D1 Knock‐in Mice and Rhesus Monkeys. The FASEB Journal. 30(S1).
7.
Alling, Torey, Mai A. Bailey, Megan Files, et al.. (2015). Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity. Journal of Medicinal Chemistry. 58(18). 7273–7285. 34 indexed citations
8.
Odingo, Joshua, Theresa O’Malley, Edward A. Kesicki, et al.. (2014). Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents. Bioorganic & Medicinal Chemistry. 22(24). 6965–6979. 26 indexed citations
9.
Cheng, Yong, Garrett C. Moraski, Jeffrey W. Cramer, Marvin J. Miller, & Jeffrey S. Schorey. (2014). Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model. PLoS ONE. 9(1). e87483–e87483. 50 indexed citations
10.
O’Malley, Theresa, Edward A. Kesicki, Torey Alling, et al.. (2014). Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979. 24 indexed citations
11.
Moraski, Garrett C., Lowell D. Markley, Jeffrey W. Cramer, et al.. (2013). Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis. ACS Medicinal Chemistry Letters. 4(7). 675–679. 88 indexed citations
12.
Gehlert, Donald R., Jeffrey W. Cramer, & Stéphanie Morin. (2012). Effects of Corticotropin-Releasing Factor 1 Receptor Antagonism on the Hypothalamic-Pituitary-Adrenal Axis of Rodents. Journal of Pharmacology and Experimental Therapeutics. 341(3). 672–680. 6 indexed citations
13.
Cramer, Jeffrey W., Brian Mattioni, & Kenneth A. Savin. (2010). Strategies for conducting ADME studies during lead generation in the drug discovery process.. PubMed. 13(12). 857–61. 2 indexed citations
14.
15.
Jesudason, Cynthia D., Lisa S. Beavers, Jeffrey W. Cramer, et al.. (2006). Synthesis and SAR of novel histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3415–3418. 32 indexed citations
16.
Sindelar, Dana K., et al.. (2004). Central H3R activation by thioperamide does not affect energy balance. Pharmacology Biochemistry and Behavior. 78(2). 275–283. 19 indexed citations
17.
Hyslop, Paul A., Patrick C. May, James E. Audia, et al.. (2004). P1-180 Reduction in a-beta(1-40) and A-beta(1-42) in CSF and plasma in the beagle dog following acute oral dosing of the gamma secretase inhibitor, LY450139. Neurobiology of Aging. 25. S147–S147. 12 indexed citations
18.
Cirrito, John R., Patrick C. May, Mark Odell, et al.. (2003). In VivoAssessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life. Journal of Neuroscience. 23(26). 8844–8853. 321 indexed citations
19.
Cirrito, John R., Patrick C. May, Mark Odell, et al.. (2003). In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.. PubMed. 23(26). 8844–53. 360 indexed citations
20.
Burkey, Jennifer, et al.. (2002). Disposition of LY333531, a selective protein kinase Cβinhibitor, in the Fischer 344 rat and beagle dog. Xenobiotica. 32(11). 1045–1052. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey S. Nissen Breakdown of academic impact, for papers by Jacques Bruhwyler Breakdown of academic impact, for papers by W. Gsell Breakdown of academic impact, for papers by Mathias Hallberg Breakdown of academic impact, for papers by Péter Serfózó Breakdown of academic impact, for papers by Suzhen Dong Breakdown of academic impact, for papers by Kenji Onodera Breakdown of academic impact, for papers by Natasja de Bruin Breakdown of academic impact, for papers by Jean‐Marie Gillardin Breakdown of academic impact, for papers by F. Gualtieri
Rankless by CCL
2026